A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Columbia University, New York

Montefiore Medical Center, The Bronx

Roswell Park, Buffalo

Johns Hopkins University, Baltimore

Mayo Clinic Jacksonville, Jacksonville

University of Florida, Gainesville

AdventHealth Orlando, Orlando

SCRI Oncology Partners, Nashville

University of Tennessee Medical Center, Knoxville

Cleveland Clinic, Cleveland

Gabrail Cancer Center, Canton

Mayo Clinic Rochester, Rochester

Northwestern University, Chicago

University of Chicago, Chicago

Washington University School of Medicine, Siteman Cancer Center, St Louis

Ochsner Clinic Foundation, New Orleans

Texas Oncology - Dension, Denison

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

Texas Oncology - Northeast Texas, Tyler

The University of Texas MD Anderson Cancer Center, Houston

Texas Oncology - San Antonio, San Antonio

Texas Oncology - Austin, Austin

Rocky Mountain Cancer Centers, LLP, Aurora

Mayo Clinic Arizona, Phoenix

The University of New Mexico, Albuquerque

Memorial Medical Center, Las Cruces

University of Southern California Norris Comprehensive Cancer Center, Los Angeles

Stanford Medicine Cancer Center, Palo Alto

Virginia Mason Franciscan Health, Seattle

Northwest Cancer Specialists, P.C., Vancouver

University of Arizona, Tucson

University of California San Francisco, San Francisco

Massachusetts General Hospital, Boston

Rutgers Cancer Institute, New Brunswick